Moderna Inc

NASDAQ:MRNA   3:59:59 PM EDT
121.00
+2.75 (+2.33%)
4:01:37 PM EDT: $121.01 +0.01 (+0.01%)
Products, Regulatory, Other Pre-Announcement

Ministry Of Health, Labour And Welfare In Japan Approves Partial Change To Moderna's Omicron-Targeting Bivalent Booster Covid-19 Vaccine

Published: 09/13/2022 04:05 GMT
Moderna Inc (MRNA) - Ministry of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna's Omicron-targeting Bivalent Booster Covid-19 Vaccine, Mrna-1273.214.
Approval From Mhlw is Based on Clinical Trial Data From a Phase 2/3 Trial, in Which Mrna-1273.214 Met All Primary Endpoints.
Approval From Mhlw is Based on Clinical Trial Data From a Phase 2/3 Trial.
Supply is Expected to Commence During September.